Non-alcoholic steatohepatitis
- 1 April 2006
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 13 (2) , 119-126
- https://doi.org/10.1097/01.med.0000216959.98385.02
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Statins and hepatotoxicityHepatology, 2005
- Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 DiabetesDiabetes, 2005
- A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitisClinical Gastroenterology and Hepatology, 2004
- Liver Damage in Severely Obese Patients: a Clinical-Biochemical-Morphologic Study on 1,000 Liver BiopsiesObesity Surgery, 2004
- Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight lossHepatology, 2004
- Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicityGastroenterology, 2004
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Hepatology, 2004
- The Importance of Routine Liver Biopsy in Diagnosing Nonalcoholic Steatohepatitis in Bariatric PatientsObesity Surgery, 2004
- Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosisSurgery, 2003